Analysis of Can Fite manpower and management performance can provide insight into Can Fite stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Can Fite BioPharma future performance. Check also Trending Equities.
Can Fite Management EffectivenessThe company has return on total asset (ROA) of (33.5) % which means that it has lost $33.5 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (99.52) % meaning that it generated substantial loss on money invested by shareholders.
Can Fite Workforce Comparison
Can Fite BioPharma Ltd is rated below average in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 1,059. Can Fite maintains roughly 7.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
Can Fite Profit MarginsThe company has Profit Margin (PM) of (133.93) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (143.34) % which suggests for every $100 dollars of sales it generated a net operating loss of -1.43.
Can Fite Stakeholders
Can Fite employes about 7 people. The company is managed by 6 executives with total tenure of roughly 77 years, averanging almost 12.0 years of service per executive having 1.0 employee per reported executive.
|Revenue Per Employee||517.1 K|
|Revenue Per Executive||603.3 K|
|Net Loss Per Employee||691.4 K|
|Net Loss Per Executive||806.7 K|